BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 23, 2026
Home
»
Topics
»
Disease categories and therapies
» Urology
Urology
RSS
EMD-221963, a representative NHE-3 inhibitor from Merck KGaA
May 17, 2001
NDA filed in Hong Kong for NexMed's ED treatment
May 16, 2001
Tanabe Seiyaku issued patent covering new PDE5 inhibitors and their use
May 11, 2001
Watson seeks FDA approval for overactive bladder treatment
May 4, 2001
Kissei and Daiichi will codevelop and comarket BPH Rx in Japan
May 3, 2001
Cialis demonstrates extended duration in clinical trials in ED
May 3, 2001
Tolterodine ER shows improved efficacy and safety
May 2, 2001
Senetek's Invicorp well tolerated for ED in hypertensive patients
April 25, 2001
Senetek's Invicorp safe and effective for severe ED in diabetics
April 24, 2001
Newly synthesized PDE5 inhibitor is more potent and selective than sildenafil
April 19, 2001
Previous
1
2
…
248
249
250
251
252
253
254
255
256
…
318
319
Next